Tech Company Financing Transactions
Castle Creek Pharmaceuticals Funding Round
Castle Creek Pharmaceuticals closed a $48 million funding round on 10/5/2016. Investors included Fidelity Management & Research Company.
Transaction Overview
Company Name
Announced On
10/5/2016
Transaction Type
Venture Equity
Amount
$48,000,000
Round
Undisclosed
Proceeds Purpose
Castle Creek will use the funds to complete development of its late-stage clinical pipeline, including its lead program for the treatment of patients with epidermolysis bullosa simplex, which will be starting a clinical registration trial in the fourth quarter of this year.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
233 Mt. Airy Rd. 1st Floor
Basking Ridge, NJ 07920
USA
Basking Ridge, NJ 07920
USA
Phone
Website
Email Address
Overview
Castle Creek Pharma is a high-growth biopharmaceutical company that has rapidly assembled a robust and diversified late-stage pipeline of products backed by strong science and focused on meeting patient needs in the treatment of rare and debilitating dermatologic and head and neck conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Wujek
Chief Medical Officer
Mary Spellman
VP - Operations
Ronald Ritz
Browse more venture capital transactions:
Prev: 10/5/2016: Aspire Health venture capital transaction
Next: 10/5/2016: Green Blender venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs